Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2002
05/23/2002US20020061908 S-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methy l-1-oxo-1H,5H-benzo(i,j)quinolizine-2-carboxylic acid arginine salt microbiocides
05/23/2002US20020061896 Imidazopyrimidine nucleoside analogues with anti-HIV activity
05/23/2002US20020061892 Antiviral azaindole derivatives
05/23/2002US20020061881 Compounds, compositions, and methods for stimulating neuronal growth and elongation
05/23/2002US20020061880 New compounds, their preparation and use
05/23/2002US20020061876 Compounds, their preparation and use
05/23/2002US20020061865 Bicyclic heterocycles that inhibit cyclin-dependent kinase or tyrosine kinase enzymes, or both, for treatment of proliferative disorders
05/23/2002US20020059684 Including coumarins, rhodamines, and rhodols that incorporate additional fused aromatic rings; absorb at a longer wavelength than structurally similar dyes that do not possess the fused aromatic rings; dye conjugates; reactive dyes
05/23/2002DE10131987A1 New pyridinyl-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
05/23/2002DE10122895A1 New lactam-substituted pyrazolo(3,4-b)pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
05/23/2002DE10057754A1 New cyclic sulfonamido-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
05/23/2002DE10057751A1 New carbamate-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation
05/23/2002CA2447553A1 Saframycins, analogues and uses thereof
05/23/2002CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
05/23/2002CA2428844A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
05/23/2002CA2428335A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
05/23/2002CA2427656A1 Crf receptor antagonists and methods relating thereto
05/23/2002CA2425117A1 Dibenzoxazepine alpha v integrin receptor antagonist
05/22/2002EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones
05/22/2002EP1206469A1 Antibacterial heterobicyclic substituted phenyl oxazolidinones
05/22/2002EP1206281A1 Moxifloxacin formulation containing common salt
05/22/2002EP1206265A1 Src kinase inhibitor compounds
05/22/2002EP1206262A1 Npy antagonists: spiroisoquinolinone derivatives
05/22/2002EP1206260A1 Src kinase inhibitor compounds
05/22/2002CN1350539A Imidazo-containing heterocyclic compounds, their compositions and uses
05/22/2002CN1350523A Indoline derivatives as progesterohe antagonists
05/22/2002CN1350520A Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
05/22/2002CN1350458A Protease inhibitors
05/22/2002CN1085079C Use of granisetron for the treatment of post-operative hausea and uomitting
05/21/2002US6392103 Using organometallic compound as catalyst
05/21/2002US6392044 Using base
05/21/2002US6391907 Anticancer agents; contraceptives
05/21/2002US6391897 (4'-benzofuran-3-yl-biphenyl-4-yloxy)-acetic acid, for example; inhibit protein-tyrosine phosphatases (ptpases)
05/21/2002US6391889 Potent antimicrobial activity on broad range of microorganisms, e.g., staphylococcus, grampositive bacteria and quinolone antibiotic resistance; side effect reduction; nontoxic
05/21/2002US6391104 Perylene pigment compositions
05/21/2002CA2215310C Substrates for beta-lactamase and uses thereof
05/16/2002WO2002038572A1 N-([1,2,4]triazoloazinyl) thiophenesulfonamide compounds as herbicides
05/16/2002WO2002038563A2 Condensed pyrazindione derivatives as pde inhibitors
05/16/2002WO2002038562A1 Bicyclic triazolone derivatives and herbicides containing the same
05/16/2002WO2002038561A1 Indolylmaleimide derivatives as protein kinase c inhibitors
05/16/2002WO2002038559A1 1,3-diazaheterocyclic compounds and their use as oral hypoglycaemic agents
05/16/2002WO2002038552A1 A novel method for the preparation of piperazine and its derivatives
05/16/2002WO2002038549A1 Hetero-anellated ortho-aminophenols and their use as dye components
05/16/2002WO2002038156A2 Methods of use of fluoroquinolone compounds against pathogenic helicobacter bacteria
05/16/2002WO2002037927A2 Compounds and methods for promoting smoking cessation
05/16/2002WO2002030891A8 Aliphatic nitrogenous five-membered ring compounds
05/16/2002WO2002030890A8 Nitrogenous five-membered ring compounds
05/16/2002WO2002014414A3 Functionalized perylene tetracarboxylic acid diimides
05/16/2002WO2001087308B1 Treatment of fibromyalgia and chronic fatigue syndrome
05/16/2002WO2001087038A3 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE
05/16/2002WO2001083459A3 Uracil substituted phenyl sulfamoyl carboxamides
05/16/2002WO2001079195A3 Pyridine and pyrazine derivatives as thrombin inhibitors
05/16/2002WO2001030753A9 Enhancement of production of camptothecins from plants
05/16/2002US20020058813 Spiro-indolines as Y5 receptor antagonists
05/16/2002US20020058811 Naphthalene derivatives
05/16/2002US20020058674 Used for therapy of conditions associated with mucosal surfaces such as cervical dysphasia and cervical intraepithelial neoplasia
05/16/2002US20020058663 Inhibitors of proton-gated cation channels and their use in the treatment of ischaemic disorders
05/16/2002US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives
05/16/2002US20020058290 Stable genetically engineered muscle cell; for use in the generation of modulators for treatment of cancer, metabolic defects, cachexia and aging defects
05/16/2002DE10056312A1 New 1-(N-substituted amidoalkyl) bicyclic uracil derivatives useful as medicaments for treating ischemia or reperfusion damage, are poly-(ADP-ribose)-synthetase inhibitors
05/16/2002CA2428125A1 A bicyclic triazolone derivative and a herbicide containing the said derivative
05/16/2002CA2427816A1 N-(¢1,2,4!triazoloazinyl) thiophenesulfonamide compounds as herbicides
05/15/2002EP1204665A2 Chemokine receptor antagonists and methods of use therefor
05/15/2002EP1204664A1 Chemokine receptor antagonists and methods of use therefor
05/15/2002EP1204663A1 Novel spiro compounds
05/15/2002EP1204662A1 Azaindoles having serotonin receptor affinity
05/15/2002EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof
05/15/2002EP1204640A2 Chemokine receptor antagonists and methods of use therefor
05/15/2002EP1204638A1 Biphenyl-substituted cyclic keto enols as pesticides
05/15/2002EP1177797A9 Novel use
05/15/2002EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
05/15/2002CN1349533A Heteroaryl diazabicycloalkanes, their prepn. and use
05/15/2002CN1349506A Heterocyclic compounds having effect of activating nicoting acetylchloine alpha 4 beta 2 receptor
05/15/2002CN1084749C 1,7-disubstituted perylene-3,4,9,10-teracarboxylic acids and dianhydrides and prepn. method therefor
05/15/2002CN1084618C Use of serotonin antagonists (5HT3) for treatment disease
05/14/2002US6388078 S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
05/14/2002US6388077 Spiro compounds
05/14/2002US6388076 Antiproliferative agents; skin disorders; osteoporosis
05/14/2002US6387923 Antiproliferative agents; anticancer agents
05/14/2002US6387922 Annulated azole derivatives useful as microbicidal agents
05/14/2002US6387919 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
05/14/2002US6387916 Administering to humans, animals
05/14/2002US6387895 Bone disorders; cardiovascular disorders
05/10/2002WO2002036734A2 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
05/10/2002WO2002036597A1 Tricyclic derivatives of indole with antiangiogenic activity
05/10/2002WO2002036593A1 Indole derivatives as pde5-inhibitors
05/10/2002WO2002036592A1 Remedies for arachidonic acid-induced skin diseases
05/10/2002WO2002036554A2 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/10/2002WO2002036123A2 New treatments for restless legs syndrome
05/10/2002WO2002022600A3 Chemokine receptor binding heterocyclic compounds
05/10/2002WO2002012238A3 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES
05/10/2002WO2002012237A3 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones
05/10/2002WO2001038326A3 Imidazo-pyridine derivatives as ligands for gaba receptors
05/10/2002WO2001029036A3 Allosteric sites on muscarinic receptors
05/10/2002WO2001023389A3 Certain alkylene diamine-substituted heterocycles
05/10/2002CA2427568A1 Tricyclic derivatives of indole with antiangiogenic activity
05/10/2002CA2425285A1 Amidino-urea serotonin receptor ligands and compositions, their pharmaceutical uses, and methods for their snythesis
05/10/2002CA2425067A1 Aza-and polyaza-naphthalenyl ketones useful as hiv integrase inhibitors
05/10/2002CA2421705A1 New treatments for restless legs syndrome
05/09/2002US20020055639 Pyrazole derivatives as herbicides